These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31090941)

  • 21. Battle Royale: Systemic Versus Locoregional Therapy for Unresectable Hepatocellular Carcinoma.
    Naugler WE
    AJR Am J Roentgenol; 2018 Jun; 210(6):1366-1367. PubMed ID: 29667887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter to the Editor: Hepatic Resection Compared to Chemoembolization in Intermediate- to Advanced-Stage Hepatocellular Carcinoma: A Comment For Moving Forward.
    Mo DC; Jia RR; Zhong JH
    Hepatology; 2019 Jul; 70(1):446-447. PubMed ID: 30520102
    [No Abstract]   [Full Text] [Related]  

  • 23. Alpha-fetoprotein in liver transplantation for hepatocellular carcinoma: The lower, the better.
    Mazzaferro V; Droz Dit Busset M; Bhoori S
    Hepatology; 2018 Aug; 68(2):775-777. PubMed ID: 29425402
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma patients awaiting liver transplantation.
    Cross T; Metussin A
    Liver Transpl; 2015 Jul; 21(7):1005. PubMed ID: 25980521
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation.
    Lai Q; Lerut J;
    Liver Transpl; 2016 Jan; 22(1):136-7. PubMed ID: 26045241
    [No Abstract]   [Full Text] [Related]  

  • 26. Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice?
    Ravaioli M; Grazi GL; Cescon M; Ercolani G; Pinna AD; Piscaglia F; Trevisani F
    Ann Surg; 2009 Aug; 250(2):348; author reply 348-9. PubMed ID: 19638902
    [No Abstract]   [Full Text] [Related]  

  • 27. Promise and Pitfalls of Using α-Fetoprotein in Liver Transplantation Allocation for Hepatocellular Carcinoma.
    Schlansky B; Orloff SL
    JAMA Surg; 2017 Jan; 152(1):64-65. PubMed ID: 27706491
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization.
    Gabr A; Abouchaleh N; Ali R; Vouche M; Atassi R; Memon K; Asadi AA; Baker T; Caicedo JC; Desai K; Fryer J; Hickey R; Abeccassis M; Habib A; Hohlastos E; Ganger D; Kulik L; Lewandowski RJ; Riaz A; Salem R
    Eur J Radiol; 2017 Aug; 93():100-106. PubMed ID: 28668402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is downstaging a reliable strategy for expanding criteria for liver transplantation in hepatocellular carcinoma?
    Ferrer-Fàbrega J; Forner A
    Lancet Oncol; 2020 Jul; 21(7):867-869. PubMed ID: 32615100
    [No Abstract]   [Full Text] [Related]  

  • 30. [Liver transplantation after tumor downstaging in hepatocellular carcinoma].
    Fritsch J; Ardelt M; Settmacher U
    Chirurg; 2020 Oct; 91(10):891. PubMed ID: 32930818
    [No Abstract]   [Full Text] [Related]  

  • 31. Transarterial chemoembolization for hepatocellular carcinoma: significance of extrahepatic collateral supply.
    Paul SB; Gamanagatti SR; Mukund A; Abbas SZ; Acharya SK
    Indian J Cancer; 2011; 48(3):339-44. PubMed ID: 21921335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical resection and liver transplantation for hepatocellular carcinoma.
    Akoad ME; Pomfret EA
    Clin Liver Dis; 2015 May; 19(2):381-99. PubMed ID: 25921669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarcopenia and AFP Level in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Binay Safer V; Eyigör S
    J Surg Res; 2019 Nov; 243():574-575. PubMed ID: 31401409
    [No Abstract]   [Full Text] [Related]  

  • 34. Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria.
    Kim Y; Stahl CC; Makramalla A; Olowokure OO; Ristagno RL; Dhar VK; Schoech MR; Chadalavada S; Latif T; Kharofa J; Bari K; Shah SA
    Surgery; 2017 Dec; 162(6):1250-1258. PubMed ID: 29033224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretransplant treatments for hepatocellular carcinoma: do they improve outcomes?
    Di Bisceglie AM
    Liver Transpl; 2005 Nov; (11 Suppl 2):S10-3. PubMed ID: 16237728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sarcopenia and AFP Level in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation: In Response.
    Acosta LF; Gedaly R; Lee JT
    J Surg Res; 2019 Nov; 243():576-577. PubMed ID: 31401410
    [No Abstract]   [Full Text] [Related]  

  • 37. Response to letter to the editors.
    Yao FY; Hameed B; Mehta N; Roberts JP
    Liver Transpl; 2014 Oct; 20(10):1285. PubMed ID: 25155484
    [No Abstract]   [Full Text] [Related]  

  • 38. Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study.
    Xue T; Le F; Chen R; Xie X; Zhang L; Ge N; Chen Y; Wang Y; Zhang B; Ye S; Ren Z
    Med Oncol; 2015 Mar; 32(3):64. PubMed ID: 25682389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR
    Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter to the Editor: Comment on Alpha-Fetoprotein Decrease From >1,000 to <500 ng/mL in Patients With Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes.
    Akbulut S; Sahin TT; Yilmaz S
    Hepatology; 2020 Dec; 72(6):2242-2243. PubMed ID: 32583464
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.